logo

Analyst Comments: Altera, Brasil Telecom, Human Genome, Exar Corp, Texas Capital
By: Zacks Investment Research   Friday, July 18, 2008 2:45 PM
Symbols: ALTR, ALU, BRP, EXAR, GSK, HGSI, SGP, TCBI, VRTX

Strong design-win activity and a solid pipeline indicate significant sales growth towards the end of the fiscal year and in fiscal 2009.

However, execution remains an issue, since there are significant hurdles between securing a design win and generating revenue from it. The company has $6.45 of net cash per share, which limits downside risk. We continue to rate shares of Exar a Hold and reiterate our target price of $9.00.

EXAR's revenue continues to grow, with Alcatel (ALU) making a 14.2% contribution in the last quarter. Networking and transmission products grew very strongly, increasing nearly 24% sequentially. SONET was the major driver within this segment, while T/E carrier devices were a mixed bag.

Design win activity was strong in the last quarter. There were 19 new products in the September quarter. The company has no long-term debt and net cash-per-share of $9.60. This provides management with operating flexibility and the option to consider share repurchases.

The communications business continues to be highly competitive, although the pricing environment has stabilized. End-user demand for telecommunications and networking equipment is still soft. The company launched several clocking products in the June quarter; however, sales continue to languish in the $20K-30K-a-quarter range. Although the recent ON business acquisition brings a potentially new growth product, this will have production ramp-up costs, which will be a drag on near-term margins.

The near-term visibility does not show promise, but longer-term growth prospects are looming. We view the softness at serial communications as temporary. Telecommunications service providers have raised capital spending budgets by roughly 5-10% for 2008, which should trickle down to the semiconductor component and device providers such as EXAR.

Texas Capital Misses Target

Texas Capital Bancshares, Inc.'s (TCBI) 2Q08 operating results were $0.22 per share versus $0.31 per share recorded in the prior-year period. Results came in well below our expectation, even though 2Q08 average portfolio loans expanded 21.3% year-over-year. The miss from expectations resulted from significantly higher-than-expected provisions for loan losses and nonperforming assets recorded for the quarter.

Within the press release, the company's guidance is now $30-33 million, or $1.12-1.23 per share. Therefore prior to the conference call, we are lowering our 2008 and 2009 earnings expectations to $1.18 per share and $1.40 per share, respectively, from $1.26 per share and $1.45 per share. We continue to view the shares of TCBI as a Hold.

Currently, the shares of TCBI trade at 1.16x its 2Q08 book value of $11.76 per share and 11.5x our new 2008 EPS target. Our new six-month target of $14.40 per share equates to 1.15x our projected 4Q08 book value of $12.45 per share. This target price also equates to 12.5x of our 2008 projected earnings per share. With no dividend to supplement the return, this equates to a 5.9% expected return over that period.


<< Previous Page12  

(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Advertisement

Related Press Releases
Popular Articles
Advertisement
Recent Articles by Zacks Investment Research
Advertisement




Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 300 contributors and press releases, SEC filings and full text news from thousands of sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia